Stay updated on Guselkumab in Active PsA: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page shows a revision update from v3.3.3 to v3.3.4, which is a minor metadata change with no impact on the study data, eligibility criteria, outcomes, locations, or scheduling. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T10:51:38.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added a comprehensive list of study locations, including multiple U.S. states and Ontario, Canada. Updated the revision label and removed the HHS Vulnerability Disclosure link.
    Difference
    1.0%
    Check dated 2025-12-17T20:14:16.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    These changes are minor editorial updates: a PubMed publication note was added and a revision tag was updated to v3.3.2, while the older PubMed note and Revision: v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-26T13:57:11.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The funding/operating status banner (the notice about a lapse in government funding and NIH Clinical Center operations) has been removed from the page.
    Difference
    0.3%
    Check dated 2025-11-19T08:37:12.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Administrative updates were made to the study record, including an updated last update date and minor wording changes. There were no changes to the study design, eligibility criteria, primary or secondary outcomes, or enrollment.
    Difference
    0.3%
    Check dated 2025-10-28T05:11:33.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    - Added a prominent notice about government funding lapse and current operating status, plus a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed reference to v3.1.0.
    Difference
    1%
    Check dated 2025-10-06T15:58:14.000Z thumbnail image

Stay in the know with updates to Guselkumab in Active PsA: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.